President Donald Trump is expected to sign an executive order that will dial back the enforcement of the Foreign Corrupt Practices Act (FCPA), a legislative measure that prohibits U.S. corporations and individuals from paying bribes to foreign officials in order to gain or maintain business. The decision has sparked debate among legal experts, corporate executives, and lawmakers, as it could mark a notable shift in U.S. policy towards international anti-bribery efforts.
The executive order is designed to alleviate what the administration views as a competitive disadvantage for American companies operating globally. Critics of the FCPA have long argued that stringent enforcement puts U.S. firms at a disadvantage when competing in international markets, where bribery may be more common and local competitors do not face similar constraints. The proposed rollback therefore prioritizes leveling the playing field for American businesses, according to statements from administration officials.
However, the prospective leniency has raised concerns regarding corporate governance and ethical standards. Many in the legal community argue that relaxing FCPA enforcement could undermine longstanding efforts to combat corporate corruption and could harm U.S. credibility in advocating for international anti-corruption standards. Observers suggest that this move could lead to an increase in unethical business practices and diminish the transparency and accountability that U.S. companies are expected to uphold.
Further reactions to this potential policy shift are expected from industries that heavily rely on international operations, including defense, pharmaceuticals, and energy sectors. Questions about how changes to FCPA enforcement will affect these industries’ compliance practices remain to be resolved.
For further developments, the original article detailing the executive order can be accessed here.